IVF Grant Program

The IVF grant program is a partnership involving Caden Lane, The Prelude Network, The Conceive Fertility Foundation, and The Wyatt Foundation to make fertility care more financially accessible for people who need in vitro fertilization to build their families. The Wyatt Foundation is the nonprofit arm of Inception Fertility and is a 501(c)(3) organization dedicated to helping individuals and couples build families through assisted reproductive technology. It was started by TJ Farnsworth, founder and CEO of Inception Fertility, and his wife Margaret Farnsworth following their experience conceiving their first child, Wyatt, through IVF. The Conceive Fertility Foundation is the nonprofit arm of Caden Lane and is also a 501(c)(3) nonprofit. It supports people affected by infertility through education and grants and was launched by Caden Lane CEO Katy Mimari following her own experience with infertility and the financial barriers associated with fertility treatment. The program will award five grants of $15,000 each to individuals who need IVF. Each $15,000 grant is intended to cover approximately the cost of one IVF cycle. The grant is solely for IVF services, although when an IVF cycle costs less than $15,000, remaining grant funds may be used for other parts of the IVF treatment, including medications, embryo testing, donor services, and embryo storage fees. The grant is not paid directly to the recipient; funds are provided directly to the recipient's clinic. Recipients may use a clinic of their choosing as long as grant-funded fertility services are performed at a U.S.-based clinic. Recipients choosing a clinic within The Prelude Network receive a 10 percent discount on fertility services performed by the Prelude Network clinic. The discount does not extend to third-party products and services such as medications, phlebotomy, anesthesia, genetic testing, and tissue storage fees. Applicants must be between 25 and 42 years old and must have a formal infertility diagnosis from a reproductive specialist or OB/GYN. A diagnosis from a doctor in another country is acceptable if it comes from a reproductive specialist or OB/GYN, but grant-funded treatment must still take place at a U.S.-based clinic. Applicants must demonstrate financial need through a U.S. Form 1040 income tax return. The FAQ for the 2026 application cycle specifies submission of the applicant's 2025 tax return and limits gross income to no more than $100,000 for a single person and no more than $150,000 for a married couple. The source also contains an earlier eligibility statement referring to a 2024 Form 1040; because the FAQ specifically addresses the 2026 application period and identifies the 2025 tax return, applicants should follow the 2025 tax return requirement for this cycle. Eligibility is not limited by marital or relationship status. People experiencing secondary infertility who already have one or more children may apply, as may applicants who have previously undergone fertility treatment. Donor egg and donor sperm may be used as part of treatment, and grant funds may be transferred to a surrogate undergoing the IVF process on the recipient's behalf. Previous applicants and previous grant recipients may reapply. Applicants may also have received grants from other organizations, although awarded funds from this program must be used within the stated grant period. Applicants with fertility benefits may apply if their benefits do not cover IVF or if IVF benefits have already been used. Anyone inside or outside the United States may apply if the applicant can submit a U.S. tax return and uses a U.S.-based clinic. The 2026 application program opens September 14, 2026, and closes November 9, 2026. The source states that applications are currently closed and will resume in the fall, which is consistent with the September opening date. Applicants are asked to submit only one application per household or family because recipients are not selected at random and duplicate applications do not increase the chance of receiving a grant. Applicants will receive a confirmation email after applying and are instructed to contact the program if they do not receive the confirmation notice. No separate letter of intent, concept paper, pre-proposal, or other pre-application gating requirement is identified in the supplied information. Grant recipients are scheduled to be notified during the week of December 14, 2026. If awarded, the grant must be used by December 2027; it has no cash value, and unused funds are forfeited after the applicable period. The source does not identify a required matching contribution or cost share, application evaluation criteria, named program contact, email address, telephone number, or direct PDF link. It also does not establish that the opportunity recurs annually or on another regular schedule, so recurrence is not assumed. The stated 2026 opening, closing, notification, and expiration dates are therefore treated as the controlling timeline for the supplied grant opportunity.

Confirm that the applicant is age 25-42, has a formal infertility diagnosis, satisfies the applicable income threshold using the required U.S. tax return, and will use a U.S.-based clinic. Applicants with fertility benefits should confirm that IVF is not covered or that applicable IVF benefits have already been used. Submit only one application per household or family.